By Dennis Thompson HealthDay ReporterTUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to blockbuster drugs Ozempic /Wegovy and ...

As such, Novo Nordisk ended its collaboration with Hims & Hers over concerns of illegal mass compounding and deceptive ...

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ...

Take a good look in the mirror — not just at your reflection, but at what it might be telling you. That belly bulge, which ...

Novo Nordisk has launched Wegovy, a once-weekly weight-loss injection, in India. The drug aims to manage obesity and reduce ...

Updates on the initial dividend picks for 2025 and a few new names. David Harrell: Hi, I’m David Harrell, editor of ...

Grocery footfall hit a five-year high over the four weeks to 15 June as take-home grocery sales grew by 4.1% compared with last year, according to the latest ...

Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in ...